Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Submitted by
admin
on October 5, 2009 - 10:32am
Source:
Bloomberg
News Tags:
Boehringer Ingelheim
diabetes
Merck
AstraZeneca
linagliptin
Headline:
Boehringer Sees ‘Uphill Battle’ With Merck, Astra in Diabetes
Do Not Allow Advertisers to Use My Personal information
